Equities

QT Imaging Holdings Inc

QT Imaging Holdings Inc

Actions
  • Price (USD)0.8987
  • Today's Change0.009 / 1.02%
  • Shares traded5.00
  • 1 Year change-91.51%
  • Beta--
Data delayed at least 15 minutes, as of May 20 2024 20:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

QT Imaging Holdings, Inc. is a medical device company. The Company is engaged in the research, development, and commercialization of body imaging systems using low energy sound. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. Its Quantitative Breast Density (QBD) is a technology that measures breast density, with no radiation or compression. The Company’s QTscan is a non-invasive breast imaging tool. In QTscan, images are generated using both reflection and transmission modalities. Its QT Imaging system uses a transmitter/receiver array pair as well as a system of reflection transceivers to create a multi-modality system (transmission and reflection). The QTscan allows for painless breast imaging with no compression, and safe imaging with no x-ray radiation. Its transmission ultrasound developments in hardware and imaging algorithms have enabled improvements in visualizing breast tissues in a natural pendant state.

  • Revenue in USD (TTM)0.00
  • Net income in USD-4.02m
  • Incorporated2021
  • Employees--
  • Location
    QT Imaging Holdings Inc3 Hamilton Landing, Suite 160NOVATO 94949United StatesUSA
  • Phone+1 (415) 842-7250
  • Fax+1 (302) 655-5049
  • Websitehttps://gigcapital5.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ALR Technologies Inc9.49k-8.00m11.76m6.00------1,238.79-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
PetVivo Holdings Inc1.05m-10.63m12.29m25.00--12.01--11.75-0.8694-0.86940.08420.060.33751.212.0441,841.60-343.12-209.90-715.73-504.6451.4120.27-1,016.55-2,297.210.6169-2,268.840.1392--693.46260.32-73.83--51.73--
STRATA Skin Sciences Inc32.55m-11.36m13.52m99.00--1.43--0.4156-0.3248-0.32480.93070.2690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
SINTX Technologies Inc2.78m-8.88m13.85m43.00--0.581--4.99-1.95-1.950.37110.19430.1381.625.8464,534.88-44.03-45.71-57.11-57.3667.9658.47-318.99-681.801.67--0.0229--68.2994.2449.75--54.10--
PAVmed Inc3.02m-71.05m17.26m107.00------5.72-9.08-9.080.3874-7.760.0588--64.1728,186.92-147.38-154.56---1,152.82-126.09---2,505.37-8,764.890.5301-8.321.82--550.40--25.76--55.51--
Dalrada Financial Corporation32.16m-21.34m17.77m0.00--2.01--0.5526-0.2388-0.23880.35730.0911.098.863.37---75.10-80.63-239.06--30.1139.23-68.78-63.941.24-21.540.3452--54.35---43.94------
Orgenesis Inc530.00k-55.36m18.92m146.00------35.70-1.97-1.970.0184-0.65830.0181.230.02923,630.14-123.09---313.24---1,080.19---12,248.68--0.2464-16.1816.82---98.53-50.94-271.82---17.71--
Agape ATP Corp1.37m-2.39m19.24m21.00--5.26--14.06-0.0312-0.03120.0180.04750.3949.4130.7965,188.57-68.48---94.72--64.84---173.78--4.99--0.0204---22.92---24.61------
QT Imaging Holdings Inc0.00-4.02m19.27m----0.8862-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
Neuraxis Inc2.46m-14.63m19.59m17.00------7.96-3.78-3.780.5432------------------87.67---594.57-----23.75-----8.37---163.78------
Meihua International Medical Tech Co Ltd97.10m11.63m19.59m617.001.590.12591.620.20180.48560.48564.066.110.578846.661.31157,372.606.9112.268.1315.0534.1938.1411.9415.475.21--0.04750.00-6.055.1086.22-5.56-9.16--
BioSig Technologies Inc18.00k-29.05m19.82m4.00------1,101.15-4.08-4.080.0025-0.32220.00610.001.094,500.00-971.23-269.73---363.1172.22---159,388.90-24,485.730.1152-------93.71---6.52---9.58--
SANUWAVE Health Inc22.41m-17.26m22.92m31.00------1.02-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
Ekso Bionics Holdings Inc17.91m-14.24m23.63m70.00--1.67--1.32-0.9685-0.96851.200.77650.54231.653.38255,900.00-43.11-43.63-57.86-57.6750.4151.93-79.48-104.242.11-34.630.2937--41.5710.03-0.7825--3.69--
Data as of May 20 2024. Currency figures normalised to QT Imaging Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

5.70%Per cent of shares held by top holders
HolderShares% Held
Cable Car Capital LLCas of 31 Mar 2024800.00k3.73%
Meteora Capital LLCas of 31 Mar 2024194.49k0.91%
HRT Financial LLCas of 31 Mar 202481.00k0.38%
Oxford Financial Group Ltd.as of 31 Mar 202461.69k0.29%
MML Investors Services LLCas of 31 Mar 202429.24k0.14%
UBS Securities LLCas of 31 Mar 202421.04k0.10%
Geode Capital Management LLCas of 31 Mar 202415.06k0.07%
Fifth Third Bank, NA (Investment Management)as of 31 Mar 202411.90k0.06%
JNBA Financial Advisors, Inc.as of 31 Mar 20247.87k0.04%
Robinson Capital Management LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.